For the past three months, the only question with cannabis firm Tilray (NASDAQ:TLRY) was whether it was better to buy the stock or smoke its products. Source: Shutterstock But that all changed (supposedly) yesterday when it announced its fiscal Q4 earnings. The day after the announcement, the stock rallied more than 25% after getting pounded…